Alimera Sciences Stock (NASDAQ:ALIM), Quotes and News Summary

Q: What sector and industry does Alimera Sciences (ALIM) operate in?

Alimera Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Alimera Sciences Stock (NASDAQ: ALIM) stock price, news, charts, stock research, profile.

Open	$3.430
Close	$3.650
Volume / Avg.	143.580K / 70.611K
Day Range	3.430 - 3.780
52 Wk Range	1.560 - 4.380
Market Cap	$178.074M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	0.53%
Days to Cover	1.18

Recent News

10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Chris Katje

Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its Class A Common Stock priced at $7.25 per share.

Lisa Levin

Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket

Gainers

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alimera Sciences (ALIM) stock?

You can purchase shares of Alimera Sciences (NASDAQ: ALIM) through any online brokerage.

View our list of the best stock brokerages.

Who are Alimera Sciences's (ALIM) competitors?

Other companies in Alimera Sciences’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Rani Therapeutics Hldgs (NASDAQ:RANI) and Aquestive Therapeutics (NASDAQ:AQST).

What is the target price for Alimera Sciences (ALIM) stock?

The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by Maxim Group on Monday, March 25, 2024. The analyst firm set a price target for 10.00 expecting ALIM to rise to within 12 months (a possible 194.12% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Alimera Sciences (ALIM)?

The stock price for Alimera Sciences (NASDAQ: ALIM) is $3.4 last updated April 25, 2024 at 9:17 AM EDT.

Does Alimera Sciences (ALIM) pay a dividend?

There are no upcoming dividends for Alimera Sciences.

When is Alimera Sciences (NASDAQ:ALIM) reporting earnings?

Alimera Sciences’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is Alimera Sciences (ALIM) going to split?

There is no upcoming split for Alimera Sciences.

What sector and industry does Alimera Sciences (ALIM) operate in?

Alimera Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-